Drug Profile
ORG 34116
Latest Information Update: 07 Sep 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Anxiolytics; Carrier proteins
- Mechanism of Action Glucocorticoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 07 Sep 2001 No-Development-Reported for Depression in Germany (Unknown route)
- 11 Jan 1999 Preclinical development for Depression in Germany (Unknown route)